UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4 + /CD8 + T cells and humoral responses in macaques

Scientific reports, 2020-12, Vol.10 (1), p.22077-22077, Article 22077

2020

Volltextzugriff (PDF)

Anal intraepithelial neoplasia and squamous cell carcinoma in HIV‐infected adults

HIV medicine, 2014-02, Vol.15 (2), p.65-76

2014

Volltextzugriff (PDF)

Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir

The Journal of infectious diseases, 1996-02, Vol.173 (2), p.321-329

1996

Volltextzugriff (PDF)

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy

Clinical and experimental immunology, 2008-05, Vol.152 (2), p.252-257

2008

Volltextzugriff (PDF)

Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a pathology distinct from ulcerative colitis

Clinical and experimental immunology, 2020-12, Vol.202 (3), p.335-352

2020

Volltextzugriff (PDF)

Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity

Journal of immunological methods, 2012-10, Vol.384 (1-2), p.51-61

2012

Volltextzugriff (PDF)

Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus type 1 (HIV-1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV-1 DNA Despite Clearance of Plasma Viremia

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.320-329

1999

Volltextzugriff (PDF)

Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay

Pathology, 2015-10, Vol.47 (6), p.564-569

2015

Volltextzugriff (PDF)

Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection

Immunology and cell biology, 2007-01, Vol.85 (1), p.6-15

2007

Volltextzugriff (PDF)

Effects of IL‐2 therapy in asymptomatic HIV‐infected individuals on proliferative responses to mitogens, recall antigens and HIV‐related antigens

Clinical and experimental immunology, 1998-07, Vol.113 (1), p.85-91

1998

Volltextzugriff (PDF)

Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts

Clinical infectious diseases, 2013-03, Vol.56 (6), p.888-897

2013

Volltextzugriff (PDF)

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses

The Journal of experimental medicine, 2001-02, Vol.193 (3), p.375-386

2001

Volltextzugriff (PDF)

Early Highly Active Antiretroviral Therapy for Acute HIV-1 Infection Preserves Immune Function of CD8+and CD4+T Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (7), p.3382-3387

2000

Volltextzugriff (PDF)

A model of primary HIV-1 infection

Mathematical biosciences, 1998-12, Vol.154 (2), p.57-85

1998

Volltextzugriff (PDF)

Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV‐infected subjects

Clinical and experimental immunology, 1999-01, Vol.115 (1), p.147-152

1999

Volltextzugriff (PDF)

Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling

AIDS research and human retroviruses, 2001-01, Vol.17 (2), p.147-159

2001

Volltextzugriff (PDF)

Transmission of triple-class, drug-resistant HIV-1 in Australia

Internal medicine journal, 2010-09, Vol.40 (9), p.657-661

2010

Volltextzugriff (PDF)

Therapeutic vaccination with p24-VLP and zidovudine augments hiv-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals

AIDS research and human retroviruses, 1999-01, Vol.15 (2), p.105-113

1999

Volltextzugriff (PDF)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes

AIDS research and human retroviruses, 2001-07, Vol.17 (11), p.1063-1066

2001

Volltextzugriff (PDF)

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection

AIDS (London), 2000-12, Vol.14 (17), p.2643-2651

2000

Volltextzugriff (PDF)

Immunological effects of antiretroviral and immune therapies for HIV

AIDS (London), 1997, Vol.11 Suppl A, p.S149-S155

1997

Volltextzugriff (PDF)

Patterns of Viral Dynamics during Primary Human Immunodeficiency Virus Type 1 Infection

The Journal of infectious diseases, 1998-12, Vol.178 (6), p.1812-1815

1998

Volltextzugriff (PDF)

Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape

Stem cells (Dayton, Ohio), 2000-01, Vol.18 (4), p.230-244

2000

Volltextzugriff (PDF)

PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA

HemaSphere, 2022-06, Vol.6, p.1958-1959

2022

Volltextzugriff (PDF)

Antibody-Dependent Effector Functions Against HIV Decline in Subjects Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2015-02, Vol.211 (4), p.529-538

2015

Volltextzugriff (PDF)

1 – 25 von 2.827

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.487)
Mit Volltextzugriff
(2.293)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.782)
Life Sciences & Biomedicine
(1.349)
Humans
(1.088)
Male
(541)
Biological And Medical Sciences
(537)
Female
(511)
Medical Sciences
(401)
Adult
(344)
Animals
(318)
Middle Aged
(294)
Physical Sciences
(274)
Immunology
(256)
Technology
(222)
Biochemistry & Molecular Biology
(209)
Aged
(184)
Fundamental And Applied Biological Sciences. Psychology
(178)
Infectious Diseases
(157)
Adolescent
(155)
Physics
(131)
Hiv
(123)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.413)
EZB Electronic Journals Library
(1.220)
Ingenta
(1.021)
LWW Total
(995)
Publisher website
(700)
IngentaConnect Journals
(502)
Elsevier ScienceDirect Journals Complete
(490)
Wiley-Blackwell Journals
(352)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(303)
Wiley Online Library Full Collection 2018
(266)
SpringerLink Journals - AutoHoldings
(162)
JSTOR
(140)
Oxford Journals
(138)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(119)
Nature_系列刊
(119)
IEEE Xplore
(107)
Oxford Journals 2020 Medicine
(96)
APS: American Physical Society E-Journals (Physics)
(94)
Taylor & Francis
(84)
PROLA - Physical Review Online Archive
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(14)

Menü

Weitere Dienste

Einstellungen

Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4 + /CD8 + T cells and humoral responses in macaques

Anal intraepithelial neoplasia and squamous cell carcinoma in HIV‐infected adults

Alterations in the Immune Response of Human Immunodeficiency Virus (HIV)-Infected Subjects Treated with an HIV-Specific Protease Inhibitor, Ritonavir

Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy

Mucosal‐associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy‐related colitis in a pathology distinct from ulcerative colitis

Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity

Potent Antiretroviral Therapy of Primary Human Immunodeficiency Virus type 1 (HIV-1) Infection: Partial Normalization of T Lymphocyte Subsets and Limited Reduction of HIV-1 DNA Despite Clearance of Plasma Viremia

Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay

Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection

Effects of IL‐2 therapy in asymptomatic HIV‐infected individuals on proliferative responses to mitogens, recall antigens and HIV‐related antigens

Impact of HIV-1 Subtype on CD4 Count at HIV Seroconversion, Rate of Decline, and Viral Load Set Point in European Seroconverter Cohorts

Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses

Early Highly Active Antiretroviral Therapy for Acute HIV-1 Infection Preserves Immune Function of CD8+and CD4+T Lymphocytes

A model of primary HIV-1 infection

Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV‐infected subjects

Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling

Transmission of triple-class, drug-resistant HIV-1 in Australia

Therapeutic vaccination with p24-VLP and zidovudine augments hiv-specific cytotoxic T lymphocyte activity in asymptomatic HIV-infected individuals

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes

Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection

Immunological effects of antiretroviral and immune therapies for HIV

Patterns of Viral Dynamics during Primary Human Immunodeficiency Virus Type 1 Infection

Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape

PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA

Antibody-Dependent Effector Functions Against HIV Decline in Subjects Receiving Antiretroviral Therapy

Suchergebnisse filtern